1. 5262Identifying higher risk patients among the COMPASS-Eligible population: An analysis from the REduction of atherothrombosis for continued health (REACH) Registry. (28th August 2018) Authors: Darmon, A; Sorbets, E; Ducrocq, G; Elbez, Y; Abtan, J; Popovic, B; Magnus Ohman, E; Rother, J; Wilson, P W F; Montalescot, G; Zeymer, U; Bhatt, D L; Steg, P G Journal: European heart journal Issue: Volume 39(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0267 Treatment paradigms in real-world practice: biologic agent use prior to and after discontinuation of abatacept in the action study. (15th June 2017) Authors: Alten, R; Lorenz, H-M; Mariette, X; Nüßlein, H; Galeazzi, M; Navarro, F; Chartier, M; Elbez, Y; Rauch, C; Bars, M Le Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1141 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. CCS patients with polyvascular disease are a high risk but heterogenous subset of patients: insights from the CLARIFY registry. (25th November 2020) Authors: Gautier, A; Ducrocq, G; Elbez, Y; Ferrari, R; Ford, I; Fox, K.M; Tardif, J.C; Tendera, M; Steg, P.G Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. FRI0245 Abatacept retention rates and prognostic factors of retention in patients with rheumatoid arthritis: 2-year results from the real-world action study. (15th June 2017) Authors: Alten, R; Lorenz, H-M; Mariette, X; Nüßlein, H; Galeazzi, M; Navarro, F; Chartier, M; Elbez, Y; Rauch, C; Bars, M Le Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 577 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P5106Prevalence, clinical characteristics and outcomes of procedural complications of percutaneous coronary intervention in non ST-elevation myocardial infarction: insights from the TAO trial. (28th August 2018) Authors: Abtan, J; Sorbets, E; Popovic, B; Elbez, Y; Mehta, S; Sabatine, M S; Wiviott, S D; Bode, C; Pollack, C V; Cohen, M; Ducrocq, G; Steg, P G Journal: European heart journal Issue: Volume 39(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗